These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3682957)

  • 61. [Which treatment for primary tuberculosis?].
    Gallet S; Bellon G
    Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 63. Diseases of the respiratory system: tuberculosis.
    Seaton A
    Br Med J; 1978 Mar; 1(6114):701-3. PubMed ID: 630304
    [No Abstract]   [Full Text] [Related]  

  • 64. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
    Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T
    Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438
    [No Abstract]   [Full Text] [Related]  

  • 66. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
    Mofredj A; Guérin JM; Leibinger F; Masmoudi R
    Infection; 1996; 24(5):390-1. PubMed ID: 8923052
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
    East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
    Snider DE; Graczyk J; Bek E; Rogowski J
    Am Rev Respir Dis; 1984 Dec; 130(6):1091-4. PubMed ID: 6508006
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
    Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
    Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Chemotherapy of tuberculosis].
    Luu Duc Cuong
    Biol Med (Paris); 1970; 59(6):471-561. PubMed ID: 4325981
    [No Abstract]   [Full Text] [Related]  

  • 72. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intermittent chemotherapy for adults with tuberculosis.
    Am Rev Respir Dis; 1974 Sep; 110(3):374-6. PubMed ID: 4413938
    [No Abstract]   [Full Text] [Related]  

  • 74. Modern management of tuberculosis.
    Promisloff RA; Johnston RF
    Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
    [No Abstract]   [Full Text] [Related]  

  • 75. Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?
    Barcena R; Oton E; Angeles Moreno M; Fortún J; Garcia-Gonzalez M; Moreno A; de Vicente E
    Am J Transplant; 2005 Nov; 5(11):2796-8. PubMed ID: 16212643
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
    Liu Z; Shilkret KL; Finelli L
    Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The predictability of hypersensitivity to anti-tuberculous drugs.
    Thompson JE
    Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug-induced heart failure in advanced pulmonary tuberculosis.
    Daynes G
    S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
    [No Abstract]   [Full Text] [Related]  

  • 80. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
    Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
    Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.